Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome

[1]  M. Samsom,et al.  Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  D. Cohen,et al.  Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[3]  T. Wittmann,et al.  Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity , 2008, Gut.

[4]  M. Hollenberg,et al.  Trypsin IV or Mesotrypsin and p23 Cleave Protease-activated Receptors 1 and 2 to Induce Inflammation and Hyperalgesia* , 2007, Journal of Biological Chemistry.

[5]  F. Nagy,et al.  A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  M. Steinhoff,et al.  Role for protease activity in visceral pain in irritable bowel syndrome. , 2007, The Journal of clinical investigation.

[7]  T. Masuko,et al.  Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: Involvement of endogenous bradykinin , 2006, Neuroscience Letters.

[8]  R. Spiller,et al.  Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes , 2006, The American Journal of Gastroenterology.

[9]  H. Fujii,et al.  Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. , 2005, American journal of surgery.

[10]  J. Wallace,et al.  A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Clark,et al.  Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario , 2004, Alimentary pharmacology & therapeutics.

[12]  A. Buret,et al.  PAR2 activation alters colonic paracellular permeability in mice via IFN‐γ‐dependent and ‐independent pathways , 2004, The Journal of physiology.

[13]  D. Santini,et al.  Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.

[14]  J. Wallace,et al.  Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Mulè,et al.  Involvement of nitric oxide and tachykinins in the effects induced by protease‐activated receptors in rat colon longitudinal muscle , 2003, British journal of pharmacology.

[16]  N. Bunnett,et al.  Proteinase-Activated Receptor-2-Induced Colonic Inflammation in Mice: Possible Involvement of Afferent Neurons, Nitric Oxide, and Paracellular Permeability1 , 2003, The Journal of Immunology.

[17]  S. Vanner,et al.  Mast cell tryptase and proteinase‐activated receptor 2 induce hyperexcitability of guinea‐pig submucosal neurons , 2003, The Journal of physiology.

[18]  Wangxue Chen,et al.  Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.

[19]  F. Mulè,et al.  Dual effect mediated by protease‐activated receptors on the mechanical activity of rat colon , 2002, British journal of pharmacology.

[20]  B. Guiard,et al.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. , 2002, Gastroenterology.

[21]  N. Bunnett,et al.  Basolateral PAR‐2 receptors mediate KCl secretion and inhibition of Na+ absorption in the mouse distal colon , 2002, The Journal of physiology.

[22]  T. Masuko,et al.  In vivo evidence that protease‐activated receptors 1 and 2 modulate gastrointestinal transit in the mouse , 2001, British journal of pharmacology.

[23]  M. Hollenberg,et al.  Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Read,et al.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea , 1996, The Lancet.

[25]  A. Larsson,et al.  The Mouse Proteinase-activated Receptor-2 cDNA and Gene , 1995, The Journal of Biological Chemistry.

[26]  Y. Fujiyama,et al.  Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor. , 1993, Internal medicine.

[27]  P. Whorwell,et al.  Symptoms of irritable bowel syndrome in ulcerative colitis in remission , 1983, Gut.

[28]  J. Lewis,et al.  Bowman-Birk Inhibitor Concentrate: A Novel Therapeutic Agent for Patients with Active Ulcerative Colitis , 2007, Digestive Diseases and Sciences.

[29]  N. Vergnolle.  Recent advances in basic science CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS ( PARS ) IN THE GUT N Vergnolle , 2005 .

[30]  A. Carmagnola.  [The mast cell]. , 1988, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.